Elixxer Ltd.
ELIXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -58.00% | 62.51% | -150.68% | 0.00% |
| EV / EBITDA | -70.96 | -149.66 | -270.10 | -10.91 |
| Quality | ||||
| ROIC | 11.09% | 8.04% | 8.40% | 13.88% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.47 | -0.01 | 0.15 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -5,572.27% | 108.32% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -67.86 | -149.53 | -268.94 | -10.86 |
| Interest Coverage | -0.21 | -0.17 | -0.18 | -0.34 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |